Biopharma’s gradual embrace of the cloud is picking up pace. In 2022, PwC surveyed more than one hundred pharmaceutical and life sciences companies. Forty percent were already running all of their operations in the cloud; another 55% hoped to join them by late this year. The report also found that the most successful companies used…
The $5-7B generative AI opportunity biopharma can’t afford to ignore
Yes, generative AI is hyped. And yes, the technology has shortcomings. But the landscape is swiftly changing. Bloomberg Intelligence estimated that the GenAI market would grow from $40 billion in 2022 to $1.3 trillion by 2032. A recent study from Deloitte Consulting estimates that for a top 10 biopharma company with $65-75 billion in revenue,…